Demo Sign up Log In

Heron Therapeutics Inc (HRTX)

Cost of Revenue

$45.24M

TTM · Period ending: Jun 30, 2026 · USD

HRTX Cost of Revenue

Latest reported$45.24Mperiod endingJun 30, 2026

Latest reported$45.24Mperiod endingJun 30, 2026

HRTX Cost of Revenue ($400.00K → $45.24M)

Annual cost of revenue

High-resolution chart · PNG

HRTX cost of revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Heron Therapeutics Inc Cost of Revenue — Annual fiscal periods (USD)
Period ending	Cost of Revenue (USD)
Dec 31, 2025	41,347,000
Dec 31, 2024	38,648,000
Dec 31, 2023	65,105,000
Dec 31, 2022	54,874,000
Dec 31, 2021	46,021,000
Dec 31, 2020	36,189,000
Dec 31, 2019	61,619,000
Dec 31, 2018	27,512,000
Dec 31, 2017	4,588,000
Dec 31, 2016	35,000
Dec 31, 2015	734,000
Dec 31, 2014	54,833,000
Dec 31, 2013	30,916,000
Dec 31, 2012	14,075,000
Dec 31, 2011	179,000
Dec 31, 2010	0
Dec 31, 2009	0
Dec 31, 2008	0
Dec 31, 2007	0
Dec 31, 2006	394,000
Dec 31, 2005	0
Dec 31, 2004	0
Dec 31, 2003	0
Dec 31, 2002	445,000
Dec 31, 2001	440,270
Dec 31, 2000	613,201
Dec 31, 1999	6,400,000
Dec 31, 1998	5,700,000
Dec 31, 1997	6,900,000
Dec 31, 1996	9,400,000
Dec 31, 1995	9,800,000
Dec 31, 1994	9,000,000
Dec 31, 1993	11,600,000
Dec 31, 1992	3,800,000
Dec 31, 1991	1,100,000
Dec 31, 1990	1,200,000
Dec 31, 1989	700,000
Dec 31, 1988	600,000
Dec 31, 1987	400,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.